Zebrafish nerve regeneration research hindered by post-Brexit regulatory friction

Research into zebrafish nerve regeneration, a potential pathway for multiple sclerosis therapeutics, is facing delays due to post-Brexit regulatory and administrative barriers. The extent to which these hurdles will permanently impede clinical translation remains uncertain, highlighting the impact of geopolitical shifts on cross-border scientific collaboration.